Captor Therapeutics ®
News
August 30, 2021
Collaboration with LifeSci Advisors
June 29, 2021
Appointment of Radosław Krawczyk as Chief Financial Officer
June 22, 2021
Resignation of the CFO and the succession plan
April 16, 2021
WSE listing ceremony invitation
April 09, 2021
Successful initial public offering of Captor Therapeutics S.A.
March 23, 2021
Captor Therapeutics S.A. rozpoczyna ofertę publiczną akcji (IPO)
March 15, 2021
Captor Therapeutics S.A. is set to conduct a public offering
March 01, 2021
Paweł Dobrzański, PhD, joins Captor Therapeutics S.A. as Biology Department Director